Cardiovascular Systems Inc (NASDAQ:CSII) gets downgraded to Underperform by Bank of America with a price target of $42.00

ME Staff
-
0

Analyst Ratings For Cardiovascular Systems Inc (NASDAQ:CSII)

Today, Cardiovascular Systems Inc (NASDAQ:CSII) stock was downgraded by Bank of America from Buy to Underperform with a price target of $42.00.

There are 2 Buy Ratings, 1 Sell Ratings, 1 Hold Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Cardiovascular Systems Inc (NASDAQ:CSII) is Hold with a consensus target price of $45.6667 per share, a potential 27.45% upside.

Some recent analyst ratings include

  • 4/11/2019-Cardiovascular Systems Inc (NASDAQ:CSII) gets downgraded to Underperform by Bank of America with a price target of $42.00
  • 10/31/2018-Cardiovascular Systems Inc (NASDAQ:CSII) had its Hold rating reiterated by Needham & Company LLC
  • 8/22/2018-Cardiovascular Systems Inc (NASDAQ:CSII) has coverage initiated with a Buy rating and $45.00 price target
  • 8/1/2018-Cardiovascular Systems Inc (NASDAQ:CSII) had its Buy rating reiterated by Lake Street Capital with a $50.00 price target
  • 12/21/2017-Cardiovascular Systems Inc (NASDAQ:CSII) had its Market Perform rating reiterated by William Blair
  • 12/4/2017-Cardiovascular Systems Inc (NASDAQ:CSII) had its Hold rating reiterated by Raymond James
  • On 11/1/2018 Martha Goldberg Aronson, Director, bought 3,000 with an average share price of $28.72 per share and the total transaction amounting to $86,160.00.
  • On 8/29/2018 Scott R Ward, CEO, bought 2,500 with an average share price of $38.39 per share and the total transaction amounting to $95,975.00.
  • On 8/17/2018 Alexander Rosenstein, General Counsel, sold 1,344 with an average share price of $37.56 per share and the total transaction amounting to $50,480.64.
  • On 8/17/2018 Jeffrey S Points, CFO, sold 971 with an average share price of $37.54 per share and the total transaction amounting to $36,451.34.
  • On 8/17/2018 Sandra Sedo, Insider, sold 862 with an average share price of $37.52 per share and the total transaction amounting to $32,342.24.
  • On 5/18/2018 Alexander Rosenstein, General Counsel, sold 190 with an average share price of $30.11 per share and the total transaction amounting to $5,720.90.
  • On 5/18/2018 Jeffrey S Points, CFO, sold 278 with an average share price of $30.09 per share and the total transaction amounting to $8,365.02.

About Cardiovascular Systems Inc (NASDAQ:CSII)
Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States. The company offers peripheral arterial disease products, including Diamondback 360 Peripheral, Predator 360, Stealth 360 Peripheral Orbital Atherectomy System (OAS), Diamondback 360 60cm Peripheral OAS, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral, Diamondback 360 2.00 Peripheral, Diamondback 360 200cm Peripheral, and Diamondback 360 180cm Peripheral, which are catheter-based platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries. Cardiovascular Systems, Inc. was founded in 1989 and is headquartered in St. Paul, Minnesota.

Recent Trading Activity for Cardiovascular Systems Inc (NASDAQ:CSII)
Shares of Cardiovascular Systems Inc closed the previous trading session at 35,78 −2,21 5,82 % with shares trading hands.